or Try an Advanced Search...

    Technical Analysis for AKYA - Akoya BioSciences, Inc.

    Grade Last Price % Change Price Change
    D 2.73 -3.02% -0.09
    AKYA closed down 3.02 percent on Friday, November 1, 2024, on 88 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Nov 14
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical AKYA trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    MACD Bearish Centerline Cross Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish -3.02%
    Bollinger Band Squeeze Range Contraction -3.02%
    BB Squeeze Started Range Contraction -3.02%
    20 DMA Resistance Bearish -6.51%
    20 DMA Resistance Bearish -5.86%
    Older End-of-Day Signals for AKYA ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Lower Bollinger Band about 19 hours ago
    Fell Below 50 DMA about 19 hours ago
    Down 2 % about 19 hours ago
    Down 1% about 19 hours ago
    Fell Below Previous Day's Low about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AKYA Chart by TradingView
    Basic chart:

    Profile

    Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Medical Instruments & Supplies
    Keywords: Disease Imaging

    Is AKYA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 28 Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
    Oct 7 Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
    Jul 11 While institutions own 21% of Akoya Biosciences, Inc. (NASDAQ:AKYA), private equity firms are its largest shareholders with 49% ownership
    May 29 We Think Some Shareholders May Hesitate To Increase Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO Compensation
    May 18 Akoya Biosciences, Inc. (AKYA) Q1 2024 Earnings Call Transcript
    May 14 Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
    May 9 Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
    May 6 Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    May 6 Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
    See more AKYA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.31
    52 Week Low 1.88
    Average Volume 128,956
    200-Day Moving Average 3.43
    50-Day Moving Average 2.79
    20-Day Moving Average 2.98
    10-Day Moving Average 2.86
    Average True Range 0.18
    RSI (14) 44.75
    ADX 18.64
    +DI 27.14
    -DI 20.65
    Chandelier Exit (Long, 3 ATRs) 2.73
    Chandelier Exit (Short, 3 ATRs) 3.04
    Upper Bollinger Bands 3.27
    Lower Bollinger Band 2.68
    Percent B (%b) 0.08
    BandWidth 19.84
    MACD Line 0.00
    MACD Signal Line 0.04
    MACD Histogram -0.039
    Fundamentals Value
    Market Cap 133.98 Million
    Num Shares 49.1 Million
    EPS -1.73
    Price-to-Earnings (P/E) Ratio -1.58
    Price-to-Sales 3.17
    Price-to-Book 4.70
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.93
    Resistance 3 (R3) 2.95 2.90 2.90
    Resistance 2 (R2) 2.90 2.85 2.89 2.89
    Resistance 1 (R1) 2.82 2.82 2.79 2.80 2.88
    Pivot Point 2.77 2.77 2.76 2.76 2.77
    Support 1 (S1) 2.68 2.72 2.66 2.66 2.58
    Support 2 (S2) 2.63 2.68 2.62 2.57
    Support 3 (S3) 2.55 2.63 2.56
    Support 4 (S4) 2.53